EV Biotech EV Biotech is a company specializing in the biological production of chemical compounds for flavors and fragrances, biomaterials, agriculture, and pharmaceutical markets. | ![]() Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | ![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | ||
Founding Date | Founding Date 2018 | Founding Date 2012 | Founding Date 2013 | Founding Date 2013 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Groningen, NL HQ | Locations Berkeley, US HQ | Locations Cambridge, GB HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US |
Employees | Employees 6 | Employees 1477% decrease | Employees 1192% decrease | Employees 20816% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 174.4 m | Valuation ($) N/A | Valuation ($) 256.5 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $11.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2025) |
Net income | Net income N/A | Net income ($148.1m) (FY, 2025) | Net income N/A | Net income ($160.1m) (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round $ 1.3m (about 8 years ago) | Latest funding round N/A | Latest funding round $ 10m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.3m | Total funding raised $ 159.5m | Total funding raised $ 11.3m | Total funding raised $ 210m |

Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View companyNuclera is a company that specializes in DNA synthesis.
View company
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company